Redox regulation by nuclear factor erythroid 2-related factor 2: Gatekeeping for the basal and diabetes-induced expression of thioredoxin-interacting protein

Molecular Pharmacology

Volumn 82, Issue 5, 2012, Pages 887-897

  He, Xiaoqing ^a   Ma, Qiang ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; REACTIVE OXYGEN METABOLITE; THIOREDOXIN INTERACTING PROTEIN; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION; GENETIC CODE; HEART; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM;

ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARDIOMYOPATHIES; CARRIER PROTEINS; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; MYOCYTES, CARDIAC; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN BINDING; RATS; REACTIVE OXYGEN SPECIES; RESPONSE ELEMENTS; THIOREDOXINS; TRANSCRIPTION, GENETIC;

EID: 84867777934     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.081133     Document Type: Article

References (46)

1. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820.
2. Chan K, Lu R, Chang JC, and Kan YW (1996) NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci USA 93:13943-13948. (Pubitemid 26424225)
3. Chen J, Saxena G, Mungrue IN, Lusis AJ, and Shalev A (2008) Thioredoxin-interacting protein: a critical link between glucose toxicity and β-cell apoptosis. Diabetes 57:938-944.
4. Chen KS and DeLuca HF (1994) Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochim Biophys Acta 1219:26-32.
5. Chutkow WA, Birkenfeld AL, Brown JD, Lee HY, Frederick DW, Yoshioka J, Patwari P, Kursawe R, Cushman SW, Plutzky J, et al. (2010) Deletion of the α-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity. Diabetes 59:1424-1434.
6. Chutkow WA, Patwari P, Yoshioka J, and Lee RT (2008) Thioredoxin- interacting protein (Txnip) is a critical regulator of hepatic glucose production. J Biol Chem 283:2397-2406.
7. Francis GS (2001) Diabetic cardiomyopathy: fact or fiction? Heart 85:247-248.
8. Giacco F and Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058-1070.
9. Han SH, Jeon JH, Ju HR, Jung U, Kim KY, Yoo HS, Lee YH, Song KS, Hwang HM, Na YS, et al. (2003) VDUP1 upregulated by TGF-beta1 and 1,25- dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 22:4035-4046. (Pubitemid 36819644)
10. Hayes JD, McMahon M, Chowdhry S, and Dinkova-Kostova AT (2010) Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid Redox Signal 13:1713-1748.
11. He X, Chen MG, Lin GX, and Ma Q (2006) Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2 • Keap1 • Cul3 complex and recruiting Nrf2 • Maf to the antioxidant response element enhancer. J Biol Chem 281:23620-23631. (Pubitemid 44274137)
12. He X, Kan H, Cai L, and Ma Q (2009) Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes. J Mol Cell Cardiol 46:47-58.
13. He X and Ma Q (2009) NRF2 cysteine residues are critical for oxidant/electrophile-sensing, Kelch-like ECH-associated protein-1-dependent ubiquitinationproteasomal degradation, and transcription activation. Mol Pharmacol 76:1265-1278.
14. He X and Ma Q (2012) Disruption of Nrf2 synergizes with high glucose to cause heightened myocardial oxidative stress and severe cardiomyopathy in diabetic mice. J Diabet Metab S7:002. http://dx.doi.org/10.4172/2155-6156.S7- 002.
15. Holmgren A (1985) Thioredoxin. Annu Rev Biochem 54:237-271.
16. Hu X, Roberts JR, Apopa PL, Kan YW, and Ma Q (2006) Accelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2 null mice. Mol Cell Biol 26:940-954. (Pubitemid 43146488)
17. Jeon JH, Lee KN, Hwang CY, Kwon KS, You KH, and Choi I (2005) Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. Cancer Res 65:4485-4489. (Pubitemid 40740780)
18. Kensler TW, Wakabayashi N, and Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47:89-116.
19. Lee KN, Kang HS, Jeon JH, Kim EM, Yoon SR, Song H, Lyu CY, Piao ZH, Kim SU, Han YH, et al. (2005) VDUP1 is required for the development of natural killer cells. Immunity 22:195-208. (Pubitemid 40255711)
20. Ma Q (2008) Xenobiotic-activated receptors: from transcription to drug metabolism to disease. Chem Res Toxicol 21:1651-1671.
21. Ma Q (2010) Transcriptional responses to oxidative stress: pathological and toxicological implications. Pharmacol Ther 125:376-393.
22. Ma Q and He X (2012) Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev doi:10.1124/pr.110.003533.
23. Ma Q, Kinneer K, Bi Y, Chan JY, and Kan YW (2004) Induction of murine NAD(P)H: quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction. Biochem J 377:205-213. (Pubitemid 38114447)
24. Minn AH, Hafele C, and Shalev A (2005) Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces β-cell apoptosis. Endocrinology 146:2397-2405. (Pubitemid 40577527)
25. Muoio DM (2007) TXNIP links redox circuitry to glucose control. Cell Metab 5:412-414.
26. Murarka S and Movahed MR (2010) Diabetic cardiomyopathy. J Card Fail 16:971-979.
27. Nguyen T, Sherratt PJ, and Pickett CB (2003) Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 43:233-260. (Pubitemid 37372641)
28. 3 up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274:21645-21650.
29. Nishizawa K, Nishiyama H, Matsui Y, Kobayashi T, Saito R, Kotani H, Masutani H, Oishi S, Toda Y, Fujii N, et al. (2011) Thioredoxin-interacting protein suppresses bladder carcinogenesis. Carcinogenesis 32:1459-1466.
30. Nordberg J and Arnér ES (2001) Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31:1287-1312. (Pubitemid 33145299)
31. Oka S, Liu W, Masutani H, Hirata H, Shinkai Y, Yamada S, Yoshida T, Nakamura H, and Yodoi J (2006) Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome. FASEB J 20:121-123. (Pubitemid 43100487)
32. Parikh H, Carlsson E, Chutkow WA, Johansson LE, Storgaard H, Poulsen P, Saxena R, Ladd C, Schulze PC, Mazzini MJ, et al. (2007) TXNIP regulates peripheral glucose metabolism in humans. PLoS Med 4:e158.
33. Patwari P, Chutkow WA, Cummings K, Verstraeten VL, Lammerding J, Schreiter ER, and Lee RT (2009) Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins. J Biol Chem 284:24996-25003.
34. Peterson CW, Stoltzman CA, Sighinolfi MP, Han KS, and Ayer DE (2010) Glucose controls nuclear accumulation, promoter binding, and transcriptional activity of the MondoA-Mlx heterodimer. Mol Cell Biol 30:2887-2895.
35. Rösen P, Nawroth PP, King G, Möller W, Tritschler HJ, and Packer L (2001) The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17:189-212. (Pubitemid 32624602)
36. Saxena G, Chen J, and Shalev A (2010) Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. J Biol Chem 285:3997-4005.
37. Sbai O, Devi TS, Melone MA, Feron F, Khrestchatisky M, Singh LP, and Perrone L (2010) RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion. J Cell Sci 123:4332-4339.
38. Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, and Lee RT (2004) Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 279:30369-30374. (Pubitemid 38937964)
39. Sheth SS, Bodnar JS, Ghazalpour A, Thipphavong CK, Tsutsumi S, Tward AD, Demant P, Kodama T, Aburatani H, and Lusis AJ (2006) Hepatocellular carcinoma in Txnip-deficient mice. Oncogene 25:3528-3536. (Pubitemid 43901674)
40. Stoltzman CA, Peterson CW, Breen KT, Muoio DM, Billin AN, and Ayer DE (2008) Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression. Proc Natl Acad Sci USA 105:6912-6917. (Pubitemid 351754504)
41. Taguchi K, Motohashi H, and Yamamoto M (2011) Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16:123-140.
42. 3-up- regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J Biol Chem 277:26496-26500.
43. Wang Z, Rong YP, Malone MH, Davis MC, Zhong F, and Distelhorst CW (2006) Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis. Oncogene 25:1903-1913.
44. Yu FX, Goh SR, Dai RP, and Luo Y (2009) Adenosine-containing molecules amplify glucose signaling and enhance txnip expression. Mol Endocrinol 23:932-942.
45. Yu FX and Luo Y (2009) Tandem ChoRE and CCAAT motifs and associated factors regulate Txnip expression in response to glucose or adenosine-containing molecules. PLoS One 4:e8397.
46. Zimmet P, Alberti KG, and Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782-787. (Pubitemid 34000780)